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http:WHAT THIS PAPER ADDS
The safety of urgent carotid endarterectomy (CEA) has been questioned. This study shows that CEA can be safely
performed within the ﬁrst few days of the onset of symptoms.Objectives: The timing of CEA for symptomatic internal carotid artery (ICA) stenosis remains a matter of
controversy. Recent registry data showed a signiﬁcantly increased risk, especially in the very early days after the
onset of symptoms. In this study the outcome of CEA in the hyperacute phase has been investigated.
Methods: The outcome of CEA for symptomatic ICA stenosis between January 2004 and December 2013 has
been retrospectively analyzed. Patients were divided into four timing groups: surgery within 0 and 2 days,
between 3 and 7 days, 8 and 14 days, and thereafter. The post-operative 30 day stroke and death rates were
assessed.
Results: A total of 761 symptomatic patients (40.1% with transient ischemic attack [TIA], 21.3% with amaurosis
fugax, and 38.6% with ischemic stroke) were included, with an overall peri-operative stroke and death rate of
3.3%. A stroke and death rate of 4.4% (9/206) for surgery within 0 and 2 days, 1.8% (4/219) between 3 and 7
days, 4.4% (6/136) between 8 and 14 days, and 2.5% (5/200) in the period thereafter (p ¼ .25 for the difference
between the groups) was observed. The timing of surgery did not inﬂuence the peri-operative outcome in a
multivariate regression analysis (OR 0.93 [0.63e1.36], p ¼ .71).
Conclusions: These data show that very urgent surgery in symptomatic patients can be performed without
increased procedural risk. Given the fact that ruptured plaques with neurological symptoms carry the highest risk
of a recurrent ischemic event in the ﬁrst 2 days, treating patients as soon as possible to offer the highest beneﬁt
in stroke prevention is recommended.
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Carotid endarterectomy (CEA) provides the best treatment
for stroke prevention in patients with recently symptomatic
stenosis of the internal carotid artery (ICA). The early days
after an initial neurological event (transient ischemic attack
[TIA] or minor stroke) carry the greatest risk of a recurrent
ischemic complication. The literature shows that the risk of
a stroke is 6.7% in the ﬁrst 2 days after a TIA and 10% after
day 7. The risks are even higher when the initial neurolog-
ical event is a minor stroke.1,2
Following the meta-analysis of the NASCET (North Amer-
ican Symptomatic Carotid Endarterectomy Trial) and ECST
(European Carotid Surgery Trial), it became clear that the
interval between qualifying event and treatment signiﬁcantly
inﬂuenced the beneﬁt of CEA.3 This knowledge provides therresponding author.
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//dx.doi.org/10.1016/j.ejvs.2014.09.006basis for recommendations to treat patients “as soon as
possible”or at least “within 2 weeks, if neurologically stable”
according to international guidelines.4e6
Recent data from a large Swedish registry questioned the
beneﬁt of very early surgery. In fact, in their multicenter
patients, Strömberg et al.7 noted that surgery was associ-
ated with a signiﬁcant increase in peri-operative complica-
tions in the very early phase (0e2 days) (mortality and any
stroke rates: 11.5% 0e2 days vs. 3.6% 3e7 days vs. 4.0% 8e
14 days vs. 5.4% 9e180 days, p < .001 for the four treat-
ment groups). Barbetta and colleagues8 also reported
increased peri-operative complication rates among CEAs
performed within 48 hours compared to surgery thereafter,
depending on the stability of the neurological deﬁcit. Tsiv-
goulis et al.9 on the other hand recently reported accept-
able peri-operative complication rates among patients
receiving surgery within 2 weeks and even for those un-
dergoing CEA within 2 days of the onset of symptoms.
The aim of this study was to analyze the peri-operative
outcome of CEA performed as soon as possible and pref-
erably within 48 hours of the initial symptoms.
Figure 1. Flow chart of patients receiving carotid endarterectomy
between January 2004 and December 2013 at the Department of
Vascular Surgery, Innsbruck Medical University.
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Patient selection
The data of all patients consecutively treated for a symp-
tomatic carotid artery stenosis between January 2004 and
December 2013 was evaluated. Patients with a severe ICA
stenosis of at least 50% and symptoms that were caused by
the stenosis (TIA, amaurosis fugax, and ischemic stroke)
were included in the analysis. Twenty three patients were
excluded because of missing information about the onset of
the neurological symptoms. For bilateral symptomatic ste-
noses with surgery on both sides (n ¼ 4), the data of sur-
gery of one side was randomly selected for statistical
analysis (Fig. 1). Indications for surgery among patients with
asymptomatic stenosis were (a) progression of the degree
of stenosis of the ICA, (b) high-grade stenosis of one ICA
with contralateral occlusion, and (c) vulnerable plaque with
a high risk of embolization.Baseline investigation
Demographic and morphological data were retrospectively
assessed from all patients. All patients were admitted to a
stroke unit and neurological status was available on
admission and on the second or third day after surgery.
Deﬁnition of the qualifying event and the time to inter-
vention. The qualifying events were categorized as TIA
(focal neurological deﬁcit lasting <24 hours), amaurosis
fugax (temporary partial or complete loss of sight caused by
transient ischemia), and ischemic stroke (cerebral ischemialasting longer than 24 hours and leading to a neurological
deﬁcit of varying severity). In addition, the modiﬁed Rankin
scale was used to assess the severity of the neurological
impairment. The Rankin scale was applied to all patients by
an experienced neurologist.
The time to surgery was calculated as days between the
qualifying neurological event and the day of surgery. For
multiple neurological events, the time frame was calculated
from the latest event to surgery. According to the timing of
surgery, the study population was divided into four groups:
CEA between 0 and 2 days, 3 and 7 days, 8 and 14 days,
thereafter (15e180 days). Patients who received surgery
more than 180 days after the qualifying event were
considered asymptomatic and were excluded from data
analysis.
Preoperative diagnostics. All patients had ultrasound
scanning for the assessment of the degree of carotid artery
stenosis and plaque morphology. In addition, cerebral im-
aging was performed either by cerebral computed tomog-
raphy (CCT) with contrast or by magnetic resonance
tomography, depending on availability and the renal func-
tion. The aims of neuro-imaging were (a) to rule out hem-
orrhage, (b) to demonstrate the presence of ischemia, (c) to
show the presence of hemodynamically compromised tis-
sue at risk or penumbra. The CCT ﬁndings were classiﬁed
into ﬁve groups according to the state and severity of
ischemia: (1) no ischemia, (2) old infarction: scar, decreased
attenuation due to absent perfusion, (3) edema: earliest
stage of brain damage with decreased peri-focal attenua-
tion, (4) leaking blood brain barrier: diffuse accumulation of
contrast medium indicating the loss of integrity of the blood
brain barrier, and (5) recent infarction: deﬁned area with
decreased cerebral blood ﬂow. For statistical analysis CCT
without pathological ﬁndings or old infarction were
grouped together. Also edema and leaking blood brain
barrier were grouped together as early stages of brain
damage.
Decision-making. In general, the aim was to perform sur-
gery as soon as possible. Parameters inﬂuencing the timing
and sometimes causing a delay in surgery were (a) the date
of referral from other hospitals or practitioners, (b) the
degree of cerebral damage in the neuro-imaging, (c) the
severity of the neurological impairment on admission and
the trend for recovery, and (d) the patient’s preference. All
these factors were individually discussed at an interdisci-
plinary meeting between neurologists, neuro-radiologists
and vascular surgeons for each patient in order to offer
the best treatment.
Carotid endarterectomy. CEA was either done as classical
endarterectomy with patch plasty or as eversion endarter-
ectomy, depending on the anatomical situation and the
surgeon’s preference. Procedures were carried out under
general anesthesia (GA) and local anesthesia (LA). From July
2010 CEA was routinely performed under LA. Surgery under
general anesthesia was routinely carried out with shunt
insertion. Shunt insertion was carried out selectively in
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logical course during carotid cross clamping. Heparin
(5,000 IU) was administered intravenously before cross
clamping in all patients. All operations were performed on
antiplatelet therapy if pre-existing. For patients not already
taking antiplatelet therapy, it was, whenever possible star-
ted at the latest, the evening before surgery. Intra-operative
angiography for quality control was routinely done except in
patients with severe renal impairment. Additionally NIRS
(near infrared spectroscopy) was applied in the last years to
compare patients undergoing surgery under LA or GA and
to determine the association between NIRS values and the
neurological status of patients in LA.Postoperative investigations
On the second or third post-operative day, an ultrasound
scan of the ICA and the neurological status of the patients
were routinely assessed. In the event of neurological
deterioration cerebral imaging was repeated. Neurological
peri-procedural complications were categorized as TIA and
stroke (increase in the modiﬁed Rankin scale of at least 1
point). Primary endpoints were all cause mortality, TIA,
stroke within 30 days of surgery, and the 30 day stroke and
death rate. For those with neurological complications in the
post-operative period, the neurological status was reas-
sessed 30 days after surgery. The 30 day mortality rate was
also documented.Statistical analysis
Comparisons of variables were performed using unpaired t-
tests, non-parametric Wilcoxon rank sum tests, Kruskale
Wallis one-way analysis of variance, and Pearson’s chi-
square test, and when appropriate in smaller numbers,
the Fisher exact test. Bootstrap was performed with 1,000
samples to determine the 95% CI for complication rates.
Variables contributing to the ﬁnal neurological complication
status were identiﬁed by logistic regression analysis.
Statistical analyses were performed with the Statistical
Package for Social Sciences for Windows (SPSS, Chicago, IL)
version 21.0.
RESULTS
Peri-operative outcome depending on the timing of
treatment
A total of 761 patients with symptomatic stenosis of the ICA
were included for data analysis. The majority of patients
(61.4%) were treated following a TIA or amaurosis fugax.
Most patients had only a mild or moderate neurological
impairment on admission (Rankin 0e2 in 90.3% of pa-
tients). The overall stroke and death rate was 3.3% (95% CI
2e4.5%). Three patients (0.4%) died within 30 days of CEA,
one following a massive cerebral hemorrhage, one due to a
myocardial infarction and one following cardiac decom-
pensation resulting from pre-existing congestive heart fail-
ure. Table 1 summarizes technical and demographic data of
the whole study population and the groups according to thetiming of treatment. A total of 206 patients (27.1%) were
treated within 2 days of the onset of symptoms, 219
(28.8%) between 3 and 7 days, 136 patients (17.9%) be-
tween 8 and 14 days, and 200 patients (26.2%) thereafter.
The majority of patients treated within the ﬁrst 2 days of
the onset of neurological symptoms presented with a TIA or
amaurosis fugax (73.8%). In contrast, 57% of patients in the
latest treatment group (15e180 days) had surgery following
an ischemic stroke. This was also shown by the Rankin
classiﬁcation: the majority of patients in the early treatment
groups showed mild impairment of neurological function
(Rankin 2), whereas patients with delayed surgery had a
higher score on the Rankin scale (Rankin <2 94.7% vs.
94.5% vs. 91.8% vs. 80.0% for the four timing groups,
p < .001) (Table 1). Outcome analysis of the timing groups
showed that patients treated in the very early days after the
onset of neurological symptoms did not suffer from an
increased number of peri-procedural complications. Com-
parable numbers of transient neurological events were
observed within the four treatment groups (2.9% vs. 1.8%
vs. 2.9% vs. 1.5% respectively, p ¼ .71). In addition, the
number of severe neurological complications leading to a
permanent deterioration of the patients neurological status
(Rankin þ 1), was comparable between the four groups
(Table 2). The overall 30 day stroke and death rate was 3.3%
(95% CI 2e4.5%) among the whole study population and
did not signiﬁcantly differ between the treatment groups
(4.4% vs. 1.8% vs. 4.4% vs. 2.5%, p ¼ .25 respectively)
(Table 2). Table 3 provides a detailed analysis of peri-
operative complications, showing that the majority of pa-
tients suffered from arterio-embolic ipsilateral complica-
tions directly after surgery. Two patients experienced
complications (one intracranial bleeding and one hyper-
perfusion syndrome with massive cerebral hemorrhage)
following cerebral thrombolysis for occlusion of the ICA.
Another patient suffered from a massive cerebral hemor-
rhage resulting from a hyperperfusion syndrome and died 2
days postoperatively.
Historical timing of treatment
Between 2004 and 2006, when the debate about early
surgery had just started, the median time interval between
neurological event and CEA was 9 days (25, 50, and 75
percentiles; 4, 9, and 22 days) at this institution. After 2006
the early treatment policy was implemented. This led to a
decrease of the median interval between ischemic event
and surgery to 6 days (25, 50, and 75 percentiles; 3, 6, and
14 days) between 2006 and 2010. Another reduction of the
interval was achieved between 2011 and 2013, when the
median delay between symptoms and surgery was 4 days
(25, 50, and 75 percentiles; 1, 5, and 13 days). Table 4
summarizes the peri-operative outcome depending on the
period of treatment.
Factors inﬂuencing the peri-operative outcome
Supplementary Table 1 shows the difference between those
patients suffering from a post-operative deterioration and
Table 1. Demographic and technical data of the study population, in total and stratiﬁed according to the four timing groups (0e2 days, 3e
7 days, 8e14 days, 15e180 days).
Total,
n ¼ 761
0e2 days,
n ¼ 206
3e7 days,
n ¼ 219
8e14 days,
n ¼ 136
15e180 days,
n ¼ 200
p*
Age, mean  SD (years) 70.1  9.7
[63; 71; 78]
70.1  10.3
[62; 71; 78]
70.9  9.4
[65; 72; 78]
71.0  9.2
[65; 72; 78]
68.5  9.5
[62; 69; 76]
.04
Gender (male), n (%) 559 (73.5) 152 (73.8) 159 (72.6) 102 (75.0) 146 (73.0) .96
Modiﬁed Rankin Scale 2, n (%) 687 (90.3) 195 (94.7) 207 (94.5) 125 (91.9) 160 (80.0) <.0001
ASA ½, n (%) 239 (31.4) 62 (30.1) 71 (32.5) 48 (35.3) 58 (29.0) .74
Symptoms ad admission
TIA, n (%) 305 (40.1) 115 (55.8) 91 (41.6) 54 (39.7) 45 (22.5)
Amaurosis, n (%) 162 (21.3) 37 (18.0) 51 (23.3) 33 (24.3) 41 (20.5) <.0001
Stroke, n (%) 294 (38.6) 54 (26.2) 77 (35.2) 49 (36.0) 114 (57.0)
Degree of stenosis
50e70%, n (%) 112 (14.7) 19 (9.2) 37 (16.9) 23 (16.9) 33 (16.5)
75e90%, n (%) 524 (68.9) 143 (69.4) 158 (72.1) 93 (68.4) 130 (65) .07
>90%, n (%) 121 (15.9) 43 (20.9) 23 (10.5) 20 (14.7) 35 (17.5)
Degree of contralateral stenosis
<50%, n (%) 529 (69.5) 145 (70.4) 145 (66.2) 98 (72.1) 141 (70.5)
50e70%, n (%) 142 (18.7) 37 (18.0) 42 (19.2) 25 (18.4) 38 (19.0) .99
75e95%, n (%) 65 (8.5) 18 (8.8) 22 (10.1) 9 (6.6) 16 (8.0)
Occlusion, n (%) 25 (3.3) 6 (2.9) 10 (4.6) 4 (2.9) 5 (2.5)
Procedure
CEA plus patch, n (%) 515 (67.7) 142 (68.9) 143 (65.3) 91 (66.9) 139 (69.5)
Eversion endarterectomy, n (%) 233 (30.6) 61 (29.6) 74 (33.8) 42 (30.9) 56 (28.0) .24
Othersa, n (%) 12 (1.7) 3 (1.5) 2 (1.0) 3 (2.2) 4 (2.0)
Shunt yes, n (%) 515 (67.7) 140 (68.0) 162 (74.0) 85 (62.5) 128 (64.0) .1
Type of anesthesia
General anesthesia, n (%) 625 (82.1) 171 (83.0) 184 (84.0) 108 (79.4) 162 (81.0) 0.68
Antiplatelet use at onset of
symptoms, n (%)
483 (63.4) 139 (67.6) 128 (60.5) 86 (63.2) 130 (65.0) 0.005
Cerebral imaging before surgery
No pathological ﬁndings, old
infarction, n (%)
604 (79.4) 168 (81.6) 177 (80.8) 109 (80.1) 150 (75.0)
Edema/leaking blood brain
barrier, n (%)
35 (4.6) 6 (2.9) 6 (2.7) 7 (5.1) 16 (8.0) 0.10
Recent infarction, n (%) 68 (8.9) 13 (6.3) 22 (10.0) 13 (9.6) 20 (10.0)
Mean  standard deviation (SD) [25th, 50th and 75th percentile in case of non-normal distribution] or number (%).Data concerning the
modiﬁed Rankin scale are available in 744 individuals, for ASA (American Society of Anesthesiology) on admission in 719, for medication
with antiplatelet therapy on admission in 755 individuals, for degree of stenosis in 759, for use of shunt in 754, and for CCT before surgery
in 707 individuals.* p-Values illustrate the overall difference between the timing groups.
a “Other procedures” combines endarterectomies with direct sutures (in dilated vessels) and interposition of a prosthesis.
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analysis showed that the timing of treatment did not in-
ﬂuence the peri-operative outcome. The only parameter
with statistical signiﬁcance for predicting the neurologicalTable 2. Thirty day perioperative outcome of the study population acco
15e180 days).
Total,
n ¼ 761
0e2 days,
n ¼ 206
TIA, n
Relative percent þ (95% CI)
17
2.2 (1.2e3.4%)
6
2.9 (0.9e5.3%)
Stroke (Rankin þ 1), n
Relative percent þ (95% CI)
23
2.9 (1.6e3.9%)
8
3.9 (1.4e6.7%)
Mortality, n
Relative percent þ (95%CI)
3
0.4 (0.0e0.9%)
1
0.5 (0.0e1.6%)
30 day stroke and death rate, n
Relative percent (95% CI)
25
3.3 (2e4.5%)
9
4.4 (1.7e7.4%)outcome of patients was the cerebral computed tomogra-
phy. Patients who underwent surgery with an already
diagnosed ischemic infarction carried a 4.5 fold increased
risk of post-operative neurological deterioration (95%rding to the timing of treatment (0e2 days, 3e7 days, 8e14 days,
3e7 days,
n ¼ 219
8e14 days,
n ¼ 136
15e180 days,
n ¼ 200
p
4
1.8 (0.4e3.9%)
4
2.9 (0.7e6.0%)
3
1.5; (0.0e3.2%)
0.71
4
1.8 (0.4e3.8%)
6
4.4 (0.9e6.1%)
5
2.5 (0.5e4.7%)
0.57
0 1
0.7 (0.0e2.4%)
1
0.5 (0.0e1.7%)
0.71
4
1.8 (0.4e3.8%)
7
5.1 (1.4e8.5%)
5
2.5 (0.5e4.7%)
0.25
Table 3. Detailed analysis of perioperative strokes and deaths.
Qualifying neurological
event (mRankin)
Timing of
treatment
Perioperative event Probable etiology Outcome at 30 days
(mRankin)
Timing Ipsi/contralateral
0 0e2 Day 1 Myocardial infarction Not applicable
0 0e2 Day 1 Ipsilateral Arterio-embolic 2
0 0e2 Day 1 Ipsilateral Arterio-embolic 1
0 0e2 Day 1 Ipsilateral Arterio-embolic 1
0 0e2 Day 1 Ipsilateral Arterio-embolic 2
1 0e2 Day 1 Ipsilateral Arterio-embolic 2
2 0e2 Day 1 Ipsilateral Arterio-embolic 3
3 0e2 Day 1 Posterior
circulation
Impaired perfusion during ICA
cross clamping in a patient
with high grade stenosis and
occlusion of the vertebral arteries
5
4 0e2 Day 1 Ipsilateral Arterio-embolic 5
2 3e7 Day 1 Ipsilateral Arterio-embolic 3
2 3e7 Day 1 Ipsilateral Arterio-embolic 3
2 3e7 Day 1 Ipsilateral Arterio-embolic 3
2 3e7 Day 1 Ipsilateral Arterio-embolic 4
0 8e14 Day 3 Cardial decompensation Not applicable
0 8e14 Day 1 Ipsilateral Arterio-embolic 3
0 8e14 Day 1 Ipsilateral Arterio-embolic 2
1 8e14 Day 2 Ipsilateral Residual plaque in the
carotid artery
2
2 8e14 Day 1 Ipsilateral Arterio-embolic 3
2 8e14 Day 1 Ipsilateral Arterio-embolic 4
3 8e14 Day 3 Ipsilateral Intracerebral bleeding,
thrombolysis for ICA occlusion
2 weeks ago, recanalization and
indication for surgery
4
1 15e180 Day 5 Ipsilateral Hyperperfusion with massive
cerebral hemorrhage, thrombolysis
for ICA occlusion 4 weeks ago,
recanalization and indication
for surgery
4
1 15e180 Day 1 Ipsilateral Arterio-embolic 3
1 15e180 Day 1 Ipsilateral Arterio-embolic 2
2 15e180 Day 2 Ipsilateral Hyperperfusion with massive
cerebral hemorrhage
6
3 15e180 Day 1 Ipsilateral Arterio-embolic 4
Carotid Endarterectomy Does Not Increase the Procedural Risk 133CI 1.71e12.06, p ¼ .002) (Table 5). It is notable that the
early stages of brain damage (edema and leaking blood
brain barrier) do not increase the risk of peri-operative
neurological deterioration (OR 2.4, 95% CI 0.51e11.45,
p ¼ .27). Also, the periods of treatment (between 2004 and
December 31, 2005; 2006 and December 31, 2010; 2011
and December 31, 2013) did not have any impact on the
peri-operative outcome.
Supplementary Table 2 summarizes the association be-
tween neurological symptoms and morphological ﬁndings
in the cerebral computed tomography.
DISCUSSION
These data show that CEA can safely be performed within
48 hours of the onset of neurological symptoms. The
comparison with other timing groups (surgery between 3
and 7 days, 8 and 14 days, and 15 and 180 days) did not
highlight an increased post-operative complication rate forthe very early treated patients. Postponement of surgery
should be considered when a recent ischemic lesion is seen
on cerebral computed tomography.
Early treatment policy and its impact on the peri-operative
neurological outcome
The treatment policy for patients with recently symptom-
atic stenosis of the ICA has moved towards rapid surgery
over the last few years. The beneﬁt of CEA is mainly inﬂu-
enced by the rate of stroke recurrence, which is extraordi-
narily high in the ﬁrst days after plaque rupture. A summary
of the latest reports of stroke recurrence from different
publications showed a range of 5% within 48 hours after the
onset of symptoms, reaching 11e25% within 14 days of the
qualifying TIA.10e15 This and the meta-analysis of the
NASCET and ECST data, showing that patients had the
greatest beneﬁt from surgery when performed within 2
weeks has resulted in a change in paradigm of treatment.3
Table 4. Outcome analysis according to the period of surgery (three time intervals).
2004e31.12.2005
n ¼ 137
01.01.2006e31.12.2010
n ¼ 378
01.01.2011e31.12.2013
n ¼ 246
p
TIA, n
Relative percent (95% CI)
4
2.9 (0.7e5.8%)
6
1.6 (0.5e2.9%)
7
2.8 (1.1e5.1%)
0.24
Stroke (Rankin þ 1), n
Relative percent þ (95% CI)
5
3.6 (0.8e6.8%)
8
2.1 (0.8e3.7%)
8
3.3% (0.4e3.8%)
0.55
Mortality, n
Relative percent þ (95%CI)
0 2
0.5 (0.0e1.6%),
2
0.8 (0.0e2.1%)
0.23
30 day stroke and death rate, n
Relative percent þ (95%CI)
5
3.6 (0.8e6.8%)
10
2.6% (1.0e4.3%)
10
4.1% (1.8e7.2%)
0.59
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for the patient when performed as soon as possible. Despite
initial apprehension this rapid treatment strategy has been
shown to be as safe as delayed surgery by different au-
thors.16e21 The discussion about timing might have already
disappeared if Strömberg and colleagues7 had not pub-
lished a series of 2,596 prospectively surveyed patients with
symptomatic stenosis of the ICA from The Swedish Vascular
Registry. The authors analyzed the inﬂuence of the timing of
treatment in four groups (0e2 days, 3e7 days, 8e14 days,
and CEA thereafter) and saw that patients who received
surgery in the very early phase suffered from signiﬁcantly
more peri-operative complications than patients in all other
treatment groups (mortality and any stroke rates: 11.5% 0e
2 days vs. 3.6% 3e7 days vs. 4.0% 8e14 days vs. 5.4% 9e
180 days, p < .001 for the four treatment groups).7 Sharpe
and colleagues10 did a similar analysis among 475 patients
with symptomatic stenosis of the ICA. The authors retro-
spectively evaluated the peri-operative outcome after CEA
depending on the timing of treatment (again surgery within
0e2 days, between 3 and 7, 8 and 14 days, and CEA
thereafter) and could not reproduce the results from the
registry analysis. Data analysis was similar to Strömberg’s
study, and in both studies the group of very early treated
patients was fairly small (n ¼ 41, 9%). Nevertheless, theTable 5. Logistic regression analysis showing parameters
contributing to a neurological deterioration (Rankin þ 1) after
carotid endarterectomy.
Variable OR (95% CI) p
Age (1 yr) 0.99 (0.95e1.03) 0.52
Gender 1.19 (0.48e2.96) 0.71
Timing of surgery (4 groups) 0.93 (0.63e1.36) 0.71
CCT prior to surgerya
No pathological ﬁndings,
old infarction (ref)
Edema, leaking blood
brain barrier
2.42 (0.51e11.45) 0.27
Recent infarction 4.54 (1.71e12.06) 0.002
Antiplatelet therapy 1.01 (0.78e1.31) 0.94
Use of shunt 1.15 (0.45e2.95) 0.77
Year of treatment 1.30 (0.68e2.49) 0.42
Type of qualifying
neurological event
0.87 (0.48e1.61) 0.67
a CCT without pathological ﬁnding or with old infarction serves as
reference category; ORs are in comparison to the reference group.peri-operative outcome was comparable between the
timing groups: 2.4% vs. 1.8% vs. 0.8% vs. 0.8% for the four
treatment groups, giving a total peri-operative stroke and
death rate of a remarkable 1.3% for the entire study pop-
ulation. In an additional step, the authors split the patients
up according to the qualifying neurological event and also
investigated the inﬂuence of age (<80 years and older) in
the timing groups. There was no reproducible difference for
the peri-operative neurological outcome for these param-
eters.10 The logistic regression analysis in this study showed
that only the state of the brain damage was predictive of
post-operative neurological deterioration. Patients who
underwent surgery with an ischemic stroke on the cerebral
imaging had a 4.5 fold increased risk of neurological com-
plications, irrespective of the timing of treatment.
Historical timing of treatment
It is remarkable that the implementation of an efﬁcient
treatment policy remains mainly for organizational reasons,
a challenge. Halliday et al.,22 for example, reported in 2009
that only 20% of patients with symptomatic stenosis of the
ICA underwent surgery within 2 weeks, with nearly one
third of patients (1,372/4,591) waiting more than 12 weeks
for the surgery. The major reason for this delay was a delay
from referral. Only 5.7% of the Swedish Registry patients
and also only 9% of Sharpe’s patients received surgery in
the ﬁrst 2 days of the onset of symptoms. In the authors’
department rapid treatment had already been imple-
mented in 2006. Close collaboration with colleagues from
the stroke unit means that CEA can now be offered on a 24/
7 basis. The importance of stroke prevention by immediate
surgery was also communicated to anesthesiologists.
Hence, all disciplines aim to try to perform CEA as soon as
possible. As a consequence, 27% of symptomatic patients
were treated within 48 hours of the onset of neurological
symptoms. Comparing the years 2004 to December 31,
2005 to October 31, 2010, and 2011 to 2013, there was a
reduction of the median period between the onset of
neurological symptoms and surgery from 9, to 6 and ﬁnally
to 4 days.
Comparison of these results with the literature
Why do Sharpe’s and these data deviate signiﬁcantly from
Strömberg’s registry data? From a systematic point of view
it is clear that prospectively collected data are more
Carotid Endarterectomy Does Not Increase the Procedural Risk 135valuable and reliable than retrospectively analyzed patient
information. Strömberg’s data constitute the ﬁrst large se-
ries collected prospectively. Such a pool of patient infor-
mation was eagerly awaited. The authors quote as one
limitation of their study that registry data are always self
reported and might therefore carry the risk of documenta-
tion bias. Mortality rates of the Swedvasc are, however,
veriﬁed by the ofﬁcial death certiﬁcates, so the mortality
rates are very reliable. Another possible factor resulting
from registry reports is the loss of detailed information on
patient selection and decision making. Information about
neuro-imaging from the registry could have been useful in
determining whether this parameter was also of inﬂuence
among this large series.
Limitations of the study
The main limitation of the data analysis is the retrospective
design. Because of referral from other hospitals, some in-
formation about the timing and severity of the neurological
symptoms was lost. In addition, some patients did not
receive a CCT for cerebral diagnostics but underwent ce-
rebral magnetic resonance imaging (MRI). These diagnostic
techniques are not comparable concerning sensitivity and
speciﬁcity in detecting signs of ischemic brain damage. In an
ongoing project, merging of the imaging techniques to also
allow decision-making on the basis of MRI ﬁndings in the
future is being attempted.
CONCLUSION
Data from a Swedish registry raised the concern that rapid
CEA carried a high risk for peri-operative complications
compared to later treatment in symptomatic patients.
A swift treatment policy for CEA in symptomatic patients
was successfully implemented over recent years. Recent
analysis demonstrated that the post-operative complication
rate was not increased in patients receiving surgery within 2
days of the onset of symptoms. Very early surgery will
continue to be offered to patients with recently symp-
tomatic stenosis of the ICA.
FUNDING
None.
CONFLICT OF INTEREST
None.
APPENDIX A. SUPPLEMENTARY DATA
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